Pain Patches Market Share

  • Report ID: 5783
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Pain Patches Market Share

North America Market Statistics

By 2037, North America region is projected to hold more than 32% pain patches market share. As per the Centers for Disease Control and Prevention; in 2015, approximately 213 million Americans aged 6 or more participated in sports & fitness activities.  With the rising number of people participating in sport-related activities, a significant number of people deal with injuries and thus require pain relief treatment. Pain patches are being considered as the most preferred option for the same.

APAC Market Analysis

During the projected period, the market for pain patches is expected to have significant expansion in the APAC region as well. The population is aging more quickly in the WHO South-East Asia Region. 9.8% of the population in 2017 is 60 years of age or more, by 2030 and 2050, this percentage will increase to 13.7% and 20.3%, respectively. By 2040, the elderly population in China is predicted to account for 28% of the country's total population due to declining birth rates and increased life expectancy. Elderly persons frequently have problems that cause chronic pain because they are more susceptible to a variety of ailments. Because of this, older consumers have a greater need for treatments resulting to the rise in pain patches market in the Asia-Pacific area.

Research Nester
Pain Patches Market Size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5783
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of pain patches is estimated at USD 5.59 billion.

The pain patches market size was valued at USD 5.39 billion in 2024 and is likely to cross USD 9.79 billion by 2037, expanding at more than 4.7% CAGR during the forecast period i.e., between 2025-2037. The market growth is impelled by increase in instances of chronic diseases, and the surge in demand for less side effect-prone pain medications.

North America industry is poised to hold largest revenue share of 32% by 2037, due to rising participation in sport-related activities among people in the region.

The major players in the market include Endo, Inc., Johnson and Johnson Private Limited, Sorrento Therapeutics, Inc., Amneal Pharmaceuticals LLC, Purdue Pharma L.P., Teva Pharmaceutical Industries Ltd., Grunenthal GmbH, NEXGEL, Inc., Viatris Inc., Pfizer Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample